Juan Lantero‐Rodriguez

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Thomas K. Karikari, Tharick A. Pascoal, Nicholas J. Ashton et al. · The Lancet Neurology · 2020 · 1.4K citations · Full text

Life Sciences, Neurology, Neuroscience +16

Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

Nicholas J. Ashton, Wagner S. Brum, Guglielmo Di Molfetta et al. · JAMA Neurology · 2024 · 768 citations · Full text

Medicine, Geriatric Medicine, Neurology +17

Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology

Tharick A. Pascoal, Thomas K. Karikari, Andréa L. Benedet et al. · Acta Neuropathologica · 2021 · 719 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected

Marc Suárez‐Calvet, Thomas K. Karikari, Juan Lantero‐Rodriguez et al. · EMBO Molecular Medicine · 2020 · 414 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline

Juan Lantero‐Rodriguez, Thomas K. Karikari, Marc Suárez‐Calvet et al. · Acta Neuropathologica · 2020 · 378 citations · Full text

Medicine, Neurology, Neuroscience +17